(2R)-8-(cyclopropylmethoxy)-2-methyl-3,5-dihydro-2H-1,5-benzoxazepin-4-one;(2R)-9-(1,6-dimethylindazol-5-yl)-2-methyl-3,5-dihydro-2H-1,5-benzoxazepin-4-one;(2R)-2-methyl-9-(3-methyl-1H-indol-2-yl)-3,5-dihydro-2H-1,5-benzoxazepin-4-one;(4R)-4-methyl-6-(1-methyl-2-oxo-3H-indol-5-yl)-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one;(4R)-4-methyl-6-[4-(2-methylsulfonylethylamino)phenyl]-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one;(4R)-4-methyl-6-(4-propanoylphenyl)-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one;(4R)-4-methyl-6-[(E)-2-pyridin-3-ylethenyl]-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one

C126H133N17O15S — CID 159866568

IUPAC(2R)-8-(cyclopropylmethoxy)-2-methyl-3,5-dihydro-2H-1,5-benzoxazepin-4-one;(2R)-9-(1,6-dimethylindazol-5-yl)-2-methyl-3,5-dihydro-2H-1,5-benzoxazepin-4-one;(2R)-2-methyl-9-(3-methyl-1H-indol-2-yl)-3,5-dihydro-2H-1,5-benzoxazepin-4-one;(4R)-4-methyl-6-(1-methyl-2-oxo-3H-indol-5-yl)-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one;(4R)-4-methyl-6-[4-(2-methylsulfonylethylamino)phenyl]-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one;(4R)-4-methyl-6-(4-propanoylphenyl)-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one;(4R)-4-methyl-6-[(E)-2-pyridin-3-ylethenyl]-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one
SMILESCCC(=O)c1ccc(-c2cccc3c2N[C@H](C)CC(=O)N3)cc1.C[C@@H]1CC(=O)Nc2ccc(OCC3CC3)cc2O1.C[C@@H]1CC(=O)Nc2cccc(-c3ccc(NCCS(C)(=O)=O)cc3)c2N1.C[C@@H]1CC(=O)Nc2cccc(-c3ccc4c(c3)CC(=O)N4C)c2N1.C[C@@H]1CC(=O)Nc2cccc(/C=C/c3cccnc3)c2N1.Cc1c(-c2cccc3c2O[C@H](C)CC(=O)N3)[nH]c2ccccc12.Cc1cc2c(cnn2C)cc1-c1cccc2c1O[C@H](C)CC(=O)N2
InChIInChI=1S/C19H23N3O3S.2C19H19N3O2.C19H18N2O2.C19H20N2O2.C17H17N3O.C14H17NO3/c1-13-12-18(23)22-17-5-3-4-16(19(17)21-13)14-6-8-15(9-7-14)20-10-11-26(2,24)25;1-11-7-17-13(10-20-22(17)3)9-15(11)14-5-4-6-16-19(14)24-12(2)8-18(23)21-16;1-11-8-17(23)21-15-5-3-4-14(19(15)20-11)12-6-7-16-13(9-12)10-18(24)22(16)2;1-11-10-17(22)20-16-9-5-7-14(19(16)23-11)18-12(2)13-6-3-4-8-15(13)21-18;1-3-17(22)14-9-7-13(8-10-14)15-5-4-6-16-19(15)20-12(2)11-18(23)21-16;1-12-10-16(21)20-15-6-2-5-14(17(15)19-12)8-7-13-4-3-9-18-11-13;1-9-6-14(16)15-12-5-4-11(7-13(12)18-9)17-8-10-2-3-10/h3-9,13,20-21H,10-12H2,1-2H3,(H,22,23);4-7,9-10,12H,8H2,1-3H3,(H,21,23);3-7,9,11,20H,8,10H2,1-2H3,(H,21,23);3-9,11,21H,10H2,1-2H3,(H,20,22);4-10,12,20H,3,11H2,1-2H3,(H,21,23);2-9,11-12,19H,10H2,1H3,(H,20,21);4-5,7,9-10H,2-3,6,8H2,1H3,(H,15,16)/b;;;;;8-7+;/t13-;12-;2*11-;2*12-;9-/m1111111/s1
InChIKeyNRUMGOKHCPZVII-LGTWCKCQSA-N
MW2157.62 g/mol
LogP23.95
Rot. Bonds16

About (2R)-8-(cyclopropylmethoxy)-2-methyl-3,5-dihydro-2H-1,5-benzoxazepin-4-one;(2R)-9-(1,6-dimethylindazol-5-yl)-2-methyl-3,5-dihydro-2H-1,5-benzoxazepin-4-one;(2R)-2-methyl-9-(3-methyl-1H-indol-2-yl)-3,5-dihydro-2H-1,5-benzoxazepin-4-one;(4R)-4-methyl-6-(1-methyl-2-oxo-3H-indol-5-yl)-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one;(4R)-4-methyl-6-[4-(2-methylsulfonylethylamino)phenyl]-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one;(4R)-4-methyl-6-(4-propanoylphenyl)-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one;(4R)-4-methyl-6-[(E)-2-pyridin-3-ylethenyl]-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one

(2R)-8-(cyclopropylmethoxy)-2-methyl-3,5-dihydro-2H-1,5-benzoxazepin-4-one;(2R)-9-(1,6-dimethylindazol-5-yl)-2-methyl-3,5-dihydro-2H-1,5-benzoxazepin-4-one;(2R)-2-methyl-9-(3-methyl-1H-indol-2-yl)-3,5-dihydro-2H-1,5-benzoxazepin-4-one;(4R)-4-methyl-6-(1-methyl-2-oxo-3H-indol-5-yl)-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one;(4R)-4-methyl-6-[4-(2-methylsulfonylethylamino)phenyl]-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one;(4R)-4-methyl-6-(4-propanoylphenyl)-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one;(4R)-4-methyl-6-[(E)-2-pyridin-3-ylethenyl]-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one (PubChem CID 159866568) has the molecular formula C126H133N17O15S and a molecular weight of 2157.62 g/mol. Its IUPAC name is (2R)-8-(cyclopropylmethoxy)-2-methyl-3,5-dihydro-2H-1,5-benzoxazepin-4-one;(2R)-9-(1,6-dimethylindazol-5-yl)-2-methyl-3,5-dihydro-2H-1,5-benzoxazepin-4-one;(2R)-2-methyl-9-(3-methyl-1H-indol-2-yl)-3,5-dihydro-2H-1,5-benzoxazepin-4-one;(4R)-4-methyl-6-(1-methyl-2-oxo-3H-indol-5-yl)-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one;(4R)-4-methyl-6-[4-(2-methylsulfonylethylamino)phenyl]-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one;(4R)-4-methyl-6-(4-propanoylphenyl)-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one;(4R)-4-methyl-6-[(E)-2-pyridin-3-ylethenyl]-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one.

Molecular Properties

Compound Name(2R)-8-(cyclopropylmethoxy)-2-methyl-3,5-dihydro-2H-1,5-benzoxazepin-4-one;(2R)-9-(1,6-dimethylindazol-5-yl)-2-methyl-3,5-dihydro-2H-1,5-benzoxazepin-4-one;(2R)-2-methyl-9-(3-methyl-1H-indol-2-yl)-3,5-dihydro-2H-1,5-benzoxazepin-4-one;(4R)-4-methyl-6-(1-methyl-2-oxo-3H-indol-5-yl)-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one;(4R)-4-methyl-6-[4-(2-methylsulfonylethylamino)phenyl]-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one;(4R)-4-methyl-6-(4-propanoylphenyl)-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one;(4R)-4-methyl-6-[(E)-2-pyridin-3-ylethenyl]-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one
PubChem CID159866568
Molecular FormulaC126H133N17O15S
Molecular Weight2157.62 g/mol
Exact Mass2155.99
IUPAC Name(2R)-8-(cyclopropylmethoxy)-2-methyl-3,5-dihydro-2H-1,5-benzoxazepin-4-one;(2R)-9-(1,6-dimethylindazol-5-yl)-2-methyl-3,5-dihydro-2H-1,5-benzoxazepin-4-one;(2R)-2-methyl-9-(3-methyl-1H-indol-2-yl)-3,5-dihydro-2H-1,5-benzoxazepin-4-one;(4R)-4-methyl-6-(1-methyl-2-oxo-3H-indol-5-yl)-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one;(4R)-4-methyl-6-[4-(2-methylsulfonylethylamino)phenyl]-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one;(4R)-4-methyl-6-(4-propanoylphenyl)-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one;(4R)-4-methyl-6-[(E)-2-pyridin-3-ylethenyl]-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one
SMILESCCC(=O)c1ccc(-c2cccc3c2N[C@H](C)CC(=O)N3)cc1.C[C@@H]1CC(=O)Nc2ccc(OCC3CC3)cc2O1.C[C@@H]1CC(=O)Nc2cccc(-c3ccc(NCCS(C)(=O)=O)cc3)c2N1.C[C@@H]1CC(=O)Nc2cccc(-c3ccc4c(c3)CC(=O)N4C)c2N1.C[C@@H]1CC(=O)Nc2cccc(/C=C/c3cccnc3)c2N1.Cc1c(-c2cccc3c2O[C@H](C)CC(=O)N3)[nH]c2ccccc12.Cc1cc2c(cnn2C)cc1-c1cccc2c1O[C@H](C)CC(=O)N2
InChIInChI=1S/C19H23N3O3S.2C19H19N3O2.C19H18N2O2.C19H20N2O2.C17H17N3O.C14H17NO3/c1-13-12-18(23)22-17-5-3-4-16(19(17)21-13)14-6-8-15(9-7-14)20-10-11-26(2,24)25;1-11-7-17-13(10-20-22(17)3)9-15(11)14-5-4-6-16-19(14)24-12(2)8-18(23)21-16;1-11-8-17(23)21-15-5-3-4-14(19(15)20-11)12-6-7-16-13(9-12)10-18(24)22(16)2;1-11-10-17(22)20-16-9-5-7-14(19(16)23-11)18-12(2)13-6-3-4-8-15(13)21-18;1-3-17(22)14-9-7-13(8-10-14)15-5-4-6-16-19(15)20-12(2)11-18(23)21-16;1-12-10-16(21)20-15-6-2-5-14(17(15)19-12)8-7-13-4-3-9-18-11-13;1-9-6-14(16)15-12-5-4-11(7-13(12)18-9)17-8-10-2-3-10/h3-9,13,20-21H,10-12H2,1-2H3,(H,22,23);4-7,9-10,12H,8H2,1-3H3,(H,21,23);3-7,9,11,20H,8,10H2,1-2H3,(H,21,23);3-9,11,21H,10H2,1-2H3,(H,20,22);4-10,12,20H,3,11H2,1-2H3,(H,21,23);2-9,11-12,19H,10H2,1H3,(H,20,21);4-5,7,9-10H,2-3,6,8H2,1H3,(H,15,16)/b;;;;;8-7+;/t13-;12-;2*11-;2*12-;9-/m1111111/s1
InChIKeyNRUMGOKHCPZVII-LGTWCKCQSA-N
XLogP23.95
TPSA418.79 Ų
H-Bond Donors13
H-Bond Acceptors23
Rotatable Bonds16
Heavy Atoms159
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002157.62
LogP ≤ 523.95
H-Bond Donors ≤ 513
H-Bond Acceptors ≤ 1023

Analyze (2R)-8-(cyclopropylmethoxy)-2-methyl-3,5-dihydro-2H-1,5-benzoxazepin-4-one;(2R)-9-(1,6-dimethylindazol-5-yl)-2-methyl-3,5-dihydro-2H-1,5-benzoxazepin-4-one;(2R)-2-methyl-9-(3-methyl-1H-indol-2-yl)-3,5-dihydro-2H-1,5-benzoxazepin-4-one;(4R)-4-methyl-6-(1-methyl-2-oxo-3H-indol-5-yl)-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one;(4R)-4-methyl-6-[4-(2-methylsulfonylethylamino)phenyl]-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one;(4R)-4-methyl-6-(4-propanoylphenyl)-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one;(4R)-4-methyl-6-[(E)-2-pyridin-3-ylethenyl]-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (2R)-8-(cyclopropylmethoxy)-2-methyl-3,5-dihydro-2H-1,5-benzoxazepin-4-one;(2R)-9-(1,6-dimethylindazol-5-yl)-2-methyl-3,5-dihydro-2H-1,5-benzoxazepin-4-one;(2R)-2-methyl-9-(3-methyl-1H-indol-2-yl)-3,5-dihydro-2H-1,5-benzoxazepin-4-one;(4R)-4-methyl-6-(1-methyl-2-oxo-3H-indol-5-yl)-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one;(4R)-4-methyl-6-[4-(2-methylsulfonylethylamino)phenyl]-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one;(4R)-4-methyl-6-(4-propanoylphenyl)-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one;(4R)-4-methyl-6-[(E)-2-pyridin-3-ylethenyl]-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one?
The IUPAC name of (2R)-8-(cyclopropylmethoxy)-2-methyl-3,5-dihydro-2H-1,5-benzoxazepin-4-one;(2R)-9-(1,6-dimethylindazol-5-yl)-2-methyl-3,5-dihydro-2H-1,5-benzoxazepin-4-one;(2R)-2-methyl-9-(3-methyl-1H-indol-2-yl)-3,5-dihydro-2H-1,5-benzoxazepin-4-one;(4R)-4-methyl-6-(1-methyl-2-oxo-3H-indol-5-yl)-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one;(4R)-4-methyl-6-[4-(2-methylsulfonylethylamino)phenyl]-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one;(4R)-4-methyl-6-(4-propanoylphenyl)-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one;(4R)-4-methyl-6-[(E)-2-pyridin-3-ylethenyl]-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one (CID 159866568) is (2R)-8-(cyclopropylmethoxy)-2-methyl-3,5-dihydro-2H-1,5-benzoxazepin-4-one;(2R)-9-(1,6-dimethylindazol-5-yl)-2-methyl-3,5-dihydro-2H-1,5-benzoxazepin-4-one;(2R)-2-methyl-9-(3-methyl-1H-indol-2-yl)-3,5-dihydro-2H-1,5-benzoxazepin-4-one;(4R)-4-methyl-6-(1-methyl-2-oxo-3H-indol-5-yl)-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one;(4R)-4-methyl-6-[4-(2-methylsulfonylethylamino)phenyl]-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one;(4R)-4-methyl-6-(4-propanoylphenyl)-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one;(4R)-4-methyl-6-[(E)-2-pyridin-3-ylethenyl]-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one.
What is the SMILES notation for (2R)-8-(cyclopropylmethoxy)-2-methyl-3,5-dihydro-2H-1,5-benzoxazepin-4-one;(2R)-9-(1,6-dimethylindazol-5-yl)-2-methyl-3,5-dihydro-2H-1,5-benzoxazepin-4-one;(2R)-2-methyl-9-(3-methyl-1H-indol-2-yl)-3,5-dihydro-2H-1,5-benzoxazepin-4-one;(4R)-4-methyl-6-(1-methyl-2-oxo-3H-indol-5-yl)-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one;(4R)-4-methyl-6-[4-(2-methylsulfonylethylamino)phenyl]-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one;(4R)-4-methyl-6-(4-propanoylphenyl)-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one;(4R)-4-methyl-6-[(E)-2-pyridin-3-ylethenyl]-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one?
The canonical SMILES for (2R)-8-(cyclopropylmethoxy)-2-methyl-3,5-dihydro-2H-1,5-benzoxazepin-4-one;(2R)-9-(1,6-dimethylindazol-5-yl)-2-methyl-3,5-dihydro-2H-1,5-benzoxazepin-4-one;(2R)-2-methyl-9-(3-methyl-1H-indol-2-yl)-3,5-dihydro-2H-1,5-benzoxazepin-4-one;(4R)-4-methyl-6-(1-methyl-2-oxo-3H-indol-5-yl)-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one;(4R)-4-methyl-6-[4-(2-methylsulfonylethylamino)phenyl]-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one;(4R)-4-methyl-6-(4-propanoylphenyl)-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one;(4R)-4-methyl-6-[(E)-2-pyridin-3-ylethenyl]-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one is CCC(=O)c1ccc(-c2cccc3c2N[C@H](C)CC(=O)N3)cc1.C[C@@H]1CC(=O)Nc2ccc(OCC3CC3)cc2O1.C[C@@H]1CC(=O)Nc2cccc(-c3ccc(NCCS(C)(=O)=O)cc3)c2N1.C[C@@H]1CC(=O)Nc2cccc(-c3ccc4c(c3)CC(=O)N4C)c2N1.C[C@@H]1CC(=O)Nc2cccc(/C=C/c3cccnc3)c2N1.Cc1c(-c2cccc3c2O[C@H](C)CC(=O)N3)[nH]c2ccccc12.Cc1cc2c(cnn2C)cc1-c1cccc2c1O[C@H](C)CC(=O)N2.
What is the InChIKey of (2R)-8-(cyclopropylmethoxy)-2-methyl-3,5-dihydro-2H-1,5-benzoxazepin-4-one;(2R)-9-(1,6-dimethylindazol-5-yl)-2-methyl-3,5-dihydro-2H-1,5-benzoxazepin-4-one;(2R)-2-methyl-9-(3-methyl-1H-indol-2-yl)-3,5-dihydro-2H-1,5-benzoxazepin-4-one;(4R)-4-methyl-6-(1-methyl-2-oxo-3H-indol-5-yl)-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one;(4R)-4-methyl-6-[4-(2-methylsulfonylethylamino)phenyl]-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one;(4R)-4-methyl-6-(4-propanoylphenyl)-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one;(4R)-4-methyl-6-[(E)-2-pyridin-3-ylethenyl]-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one?
The InChIKey is NRUMGOKHCPZVII-LGTWCKCQSA-N. The full InChI is InChI=1S/C19H23N3O3S.2C19H19N3O2.C19H18N2O2.C19H20N2O2.C17H17N3O.C14H17NO3/c1-13-12-18(23)22-17-5-3-4-16(19(17)21-13)14-6-8-15(9-7-14)20-10-11-26(2,24)25;1-11-7-17-13(10-20-22(17)3)9-15(11)14-5-4-6-16-19(14)24-12(2)8-18(23)21-16;1-11-8-17(23)21-15-5-3-4-14(19(15)20-11)12-6-7-16-13(9-12)10-18(24)22(16)2;1-11-10-17(22)20-16-9-5-7-14(19(16)23-11)18-12(2)13-6-3-4-8-15(13)21-18;1-3-17(22)14-9-7-13(8-10-14)15-5-4-6-16-19(15)20-12(2)11-18(23)21-16;1-12-10-16(21)20-15-6-2-5-14(17(15)19-12)8-7-13-4-3-9-18-11-13;1-9-6-14(16)15-12-5-4-11(7-13(12)18-9)17-8-10-2-3-10/h3-9,13,20-21H,10-12H2,1-2H3,(H,22,23);4-7,9-10,12H,8H2,1-3H3,(H,21,23);3-7,9,11,20H,8,10H2,1-2H3,(H,21,23);3-9,11,21H,10H2,1-2H3,(H,20,22);4-10,12,20H,3,11H2,1-2H3,(H,21,23);2-9,11-12,19H,10H2,1H3,(H,20,21);4-5,7,9-10H,2-3,6,8H2,1H3,(H,15,16)/b;;;;;8-7+;/t13-;12-;2*11-;2*12-;9-/m1111111/s1.
What are the key properties of (2R)-8-(cyclopropylmethoxy)-2-methyl-3,5-dihydro-2H-1,5-benzoxazepin-4-one;(2R)-9-(1,6-dimethylindazol-5-yl)-2-methyl-3,5-dihydro-2H-1,5-benzoxazepin-4-one;(2R)-2-methyl-9-(3-methyl-1H-indol-2-yl)-3,5-dihydro-2H-1,5-benzoxazepin-4-one;(4R)-4-methyl-6-(1-methyl-2-oxo-3H-indol-5-yl)-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one;(4R)-4-methyl-6-[4-(2-methylsulfonylethylamino)phenyl]-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one;(4R)-4-methyl-6-(4-propanoylphenyl)-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one;(4R)-4-methyl-6-[(E)-2-pyridin-3-ylethenyl]-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one?
(2R)-8-(cyclopropylmethoxy)-2-methyl-3,5-dihydro-2H-1,5-benzoxazepin-4-one;(2R)-9-(1,6-dimethylindazol-5-yl)-2-methyl-3,5-dihydro-2H-1,5-benzoxazepin-4-one;(2R)-2-methyl-9-(3-methyl-1H-indol-2-yl)-3,5-dihydro-2H-1,5-benzoxazepin-4-one;(4R)-4-methyl-6-(1-methyl-2-oxo-3H-indol-5-yl)-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one;(4R)-4-methyl-6-[4-(2-methylsulfonylethylamino)phenyl]-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one;(4R)-4-methyl-6-(4-propanoylphenyl)-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one;(4R)-4-methyl-6-[(E)-2-pyridin-3-ylethenyl]-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one has a molecular weight of 2157.62 g/mol, XLogP of 23.95, 16 rotatable bonds, 13 hydrogen bond donors, and 23 hydrogen bond acceptors.
Where does this data come from?
All data for (2R)-8-(cyclopropylmethoxy)-2-methyl-3,5-dihydro-2H-1,5-benzoxazepin-4-one;(2R)-9-(1,6-dimethylindazol-5-yl)-2-methyl-3,5-dihydro-2H-1,5-benzoxazepin-4-one;(2R)-2-methyl-9-(3-methyl-1H-indol-2-yl)-3,5-dihydro-2H-1,5-benzoxazepin-4-one;(4R)-4-methyl-6-(1-methyl-2-oxo-3H-indol-5-yl)-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one;(4R)-4-methyl-6-[4-(2-methylsulfonylethylamino)phenyl]-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one;(4R)-4-methyl-6-(4-propanoylphenyl)-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one;(4R)-4-methyl-6-[(E)-2-pyridin-3-ylethenyl]-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one is sourced from PubChem (CID 159866568), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).